Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Filings indexed 794 across all filing types
Latest filing 2022-05-24 Report Publication Anno…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2022 bis zum 31.03.2022
Report Publication Announcement Classification · 100% confidence The document text is very short (819 characters) and explicitly states that a financial report ('Zwischenmitteilung der Geschäftsführung' covering Q1 2022) is available on the internet ('Im Internet unter: ...'). It functions as an announcement about the publication of a report rather than the report itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. The key phrase is 'Hinweis auf Zwischenmitteilung' (Notice of Interim Report) and the provision of the link and publication date.
2022-05-24 German
Annual financial report 2021
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2021' and contains comprehensive financial statements, a management report, an auditor's report, and a letter from the management board. It covers the full fiscal year 2021 and provides detailed financial performance data, meeting the criteria for an Annual Report (10-K). FY 2021
2022-05-02 English
Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021
Earnings Release Classification · 100% confidence The document is a news release dated April 30, 2022, titled "Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021". It explicitly discusses the company's financial performance for the fiscal year 2021, providing key metrics like Revenues, EBITDA, EBIT, and Net Result, along with a forward-looking statement/forecast for 2022. The presence of detailed financial tables and the summary of annual results strongly indicate this is an Earnings Release (ER), which typically precedes or is the initial announcement of the full annual report (10-K). Since it focuses on the key highlights and results for the period, ER is the most appropriate classification over 10-K (which is the comprehensive statutory filing). It is not a full transcript (CT), a proxy statement (PSI), or a formal Audit Report (AR). FY 2021
2022-04-30 English
Vita 34 publishes revenue and earnings forecast for the 2022 financial year
Earnings Release Classification · 100% confidence The document is a short announcement (4005 characters) dated April 29, 2022, titled "Vita 34 publishes revenue and earnings forecast for the 2022 financial year." It explicitly states it is an 'Ad-hoc' disclosure under MAR Article 17 and provides specific forward-looking guidance for revenues and EBITDA for the full year 2022. This content—providing key financial projections outside of a full periodic report—is characteristic of an Earnings Release (ER) or a preliminary announcement of results/outlook. Since it is a forecast/guidance announcement rather than the full quarterly/annual report, ER is the most appropriate classification. It is not a Report Publication Announcement (RPA) because it contains the core information (the forecast figures) rather than just announcing that a report is available. FY 2022
2022-04-29 English
Report Publication Announcement 2022
Report Publication Announcement Classification · 100% confidence The document is titled "Vita 34 AG: Preliminary announcement of the publication of financial reports..." and explicitly states that it is a "Preliminary announcement of the publication of financial reports." It details the 'Report Type: Annual financial report' and provides the 'Date of disclosure: April 30, 2022' along with a link, but it is not the report itself. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached classifies as a Report Publication Announcement (RPA). The document length (2205 chars) supports this being an announcement rather than the full Annual Report (10-K).
2022-04-27 English
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
Report Publication Announcement Classification · 100% confidence The document is a short notification (788 characters) informing shareholders that the Annual Financial Report for the period 01.01.2021 to 31.12.2021 is available for download via a provided URL. It does not contain the report itself, but rather serves as a formal announcement of its publication. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2022-04-27 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.